Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Minerva Med ; 97(1): 79-93, 2006 Feb.
Article in Italian | MEDLINE | ID: mdl-16565701

ABSTRACT

Cardiac natriuretic peptides (including ANP, BNP, CNP and urodilatin) constitute a family of peptide hormones and neurotransmitters, sharing similar chemical structure (characterized by a cysteine bridge) and biological function. ANP and BNP are cardiac hormones because they are principally produced and secreted by cardiomyocytes. CNP is principally produced and secreted by endothelial cells, while urodilatin only by renal tubular cells. Natriuretic peptides share a direct diuretic, natriuretic and vasodilator effect and an inhibitory action on ventricular myocyte contraction as well as on remodeling, restenosis and other inflammatory processes of myocardium and smooth muscle cells. Cardiac natriuretic peptides share their biological action by means of specific receptors (NPR), which are present into the cell membranes of target tissues. Three different subtypes of NPRs have been so far identified in mammalian tissues. NPR-A and NPR-B are generally considered to mediate all known biological actions throughout the guanylate cyclase (GC) intracellular domain, while the third member of the natriuretic peptide receptor family, the NPR-C receptor, has not a GC domain. It is generally thought that the NPR-C is not linked to GC and so serves as a clearance receptor. Natriuretic peptides constitute a family sharing both endocrine. paracrine and autocrine actions and neurotransmitter and immuno-modulator functions. Therefore, it can be hypothesized that the cardiac natriuretic peptide system is closely related with other regulatory systems in a biological hierarchical networks.


Subject(s)
Myocardium/metabolism , Natriuretic Peptides/physiology , Atrial Natriuretic Factor/physiology , Natriuretic Peptide, Brain/physiology , Natriuretic Peptide, C-Type/physiology , Peptide Fragments/physiology , Receptors, Atrial Natriuretic Factor/physiology , Second Messenger Systems/physiology
2.
Metabolism ; 51(1): 110-4, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11782881

ABSTRACT

This study intended to test the hypothesis that intracellular lipolysis in the pancreatic beta cells is implicated in the regulation of insulin secretion stimulated by nutrient secretagogues or cyclic adenosine monophosphate (cAMP) agonists. Indeed, although lipid signaling molecules were repeatedly reported to influence beta-cell function, the contribution of intracellular triglycerides to the generation of these molecules has remained elusive. Thus, we have studied insulin secretion of isolated rat pancreatic islets in response to various secretagogues in the presence or absence of 3,5-dimethylpyrazole (DMP), a water-soluble and highly effective antilipolytic agent, as previously shown in vivo. In vitro exposure of islets to DMP resulted in an inhibition (by approximately 50%) of the insulin release stimulated not only by high glucose, but also by another nutrient secretagogue, 2-ketoisocaproate, as well as the cAMP agonists 3-isobutyl-1-methylxanthine and glucagon. The inhibitory effect of DMP, which was not due to alteration of islet glucose oxidation, could be reversed upon addition of sn-1,2-dioctanoylglycerol, a synthetic diglyceride, which activates protein kinase C. The results provide direct pharmacologic evidence supporting the concept that endogenous beta-cell lipolysis plays an important role in the generation of lipid signaling molecules involved in the control of insulin secretion in response to both fuel stimuli and cAMP agonists.


Subject(s)
Cyclic AMP/agonists , Insulin/metabolism , Islets of Langerhans/metabolism , Lipolysis/drug effects , Nutritional Physiological Phenomena , Pyrazoles/pharmacology , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , Diglycerides/pharmacology , Glucagon/pharmacology , Glucose/pharmacology , In Vitro Techniques , Insulin Secretion , Islets of Langerhans/drug effects , Keto Acids/pharmacology , Male , Rats , Rats, Sprague-Dawley
3.
J Gerontol A Biol Sci Med Sci ; 56(9): B375-83, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11524438

ABSTRACT

Autophagy is a process that sequesters and degrades organelles and macromolecular constituents of cytoplasm for cellular restructuring and repair and as a source of nutrients for metabolic use in early starvation. The effects of two antiaging dietary regimens (initiated in rats at the age of 2 months), namely, 40% dietary restriction (DR) and every-other-day ad-libitum feeding, that exhibited different effects on metabolism and similar effects on longevity on the age-related changes in the regulation of autophagic proteolysis were studied by monitoring the rate of valine release in the incubation medium from isolated liver cells of male albino Sprague-Dawley rats aged 2, 6, 12, 18, 24, and 27 months. (The liver cells were incubated in vitro with added amino acids and 10(-7) M insulin or glucagon.) Age-matched male albino Sprague-Dawley rats fed ad libitum served as a control. Results show that in ad-libitum-fed rats, after a transient increase by age 6 months, autophagic proteolysis and regulation by amino acid exhibit a dramatic age-related decline, and that the age-related changes are prevented by dietary antiaging intervention. A comparison shows that the protective effects of DR and every-other-day ad-libitum feeding are partially different in 24-month-old rats (but the beneficial effects of the two diets on regulation of autophagic proteolysis are always similar). With regard to endocrine regulation, results confirm that the liver cell response to glucagon (but not to insulin) declines with increasing age, and they show that antiaging DRs significantly improve the effects of glucagon (and have no effect on the response to insulin). The interactions of age by diet, glucagon (and in older rats, insulin), and amino acids are significant. It is concluded that DR significantly improves the susceptibility of liver cells to lysosomal degradation, and it prevents decline with increasing age. It is suggested that improved liver autophagy and lysosomal degradation might be part of the antiaging mechanisms of DR.


Subject(s)
Aging/metabolism , Autophagy , Endopeptidases/physiology , Energy Intake , Hepatocytes/metabolism , Animals , Diet , Glucagon/pharmacology , Insulin/pharmacology , Lysosomes/metabolism , Male , Rats , Rats, Sprague-Dawley
4.
J Gerontol A Biol Sci Med Sci ; 56(7): B288-93, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11445593

ABSTRACT

During intervals between meals, autophagy is a major source of nutrients and may remove damaged organelles and membranes. Age-related changes in the regulation of autophagic proteolysis were studied by monitoring the rate of valine release from liver cells of 2-, 6-, 12-, 18-, and 24-month-old male Sprague-Dawley rats fed ad libitum, and incubated in vitro with added amino acids and 10(-7) M of insulin or glucagon. The maximum rate of proteolysis and its maximum inhibition by amino acids were reached at 6 months and declined thereafter. In contrast, the rate of protein degradation in the presence of high concentrations of amino acids was not affected by aging. The inhibitor effect of insulin was additive to that of amino acids and was not altered significantly by age. The conclusion is that altered regulation of autophagic proteolysis decreases susceptibility of older cells to lysosomal degradation, and it may lead to the accumulation of altered organelles and membranes.


Subject(s)
Aging/metabolism , Autophagy , Hepatocytes/metabolism , Liver/anatomy & histology , Liver/metabolism , Valine/metabolism , Amino Acids/metabolism , Analysis of Variance , Animals , Glucagon/metabolism , Hepatocytes/enzymology , In Vitro Techniques , Insulin/metabolism , Liver/enzymology , Male , Microscopy, Electron , Rats , Rats, Sprague-Dawley
5.
Ital Heart J ; 2(6): 475-7, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11453587

ABSTRACT

A patient with a deletion in the DiGeorge/velocardiofacial chromosomal region in 22q11, underwent cardiac repair for truncus arteriosus with a separate origin of the pulmonary arteries. This patient presented with a severe coagulation disorder similar to that described in the Bernard-Soulier syndrome. Additional features included minor facial anomalies, transient hypocalcemia and renal failure. To the best of our knowledge, this is the third case of a severe bleeding disorder associated with 22q 11 deletion reported in the literature.


Subject(s)
Bernard-Soulier Syndrome/complications , Chromosomes, Human, Pair 22 , Heart Defects, Congenital/complications , Hemorrhage/complications , Chromosome Deletion , Family Health , Humans , Infant, Newborn , Male
6.
Clin Chem Lab Med ; 39(12): 1240-3, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11798084

ABSTRACT

We evaluated mRNA expression of the heat shock protein gene, Hsp70-1, by means of a semiquantitative RT-PCR in atrial tissue specimens from pediatric patients collected before and after cardiopulmonary bypass surgery for congenital heart diseases, to see whether surgical stress may affect the expression level of this mRNA. We studied thirty nine pediatric patients (aged 3 months to 15 years) undergoing surgical correction of congenital heart malformation. Twenty-one patients were affected by the tetralogy of Fallot, two by combined atrioventricular septal defects, six by ventricular septal defect, three by atrial septal defect, two by atrioventricular canal defect, two by pulmonary valve stenosis, one by mitral insufficiency, and one by double-outlet right ventricle. Our results showed no significant changes in the Hsp70-1 mRNA expression in atrial tissue of patients before and after cross-clamping (the mean relative expression after cross-clamping was 1.0+/-0.6 compared to the baseline value). Furthermore, no significant correlations were observed between cross-clamping time and temperature, cardiopulmonary bypass time and mRNA variation. Our study suggests that, during cardioplegia, myocardial tissue does not have an appropriate adaptive response to surgical stress.


Subject(s)
Gene Expression Regulation , HSP70 Heat-Shock Proteins/genetics , Heart Defects, Congenital/genetics , Heart Defects, Congenital/surgery , Adolescent , Cardiopulmonary Bypass , Child , Child, Preschool , Deoxyribonuclease I/metabolism , Female , Heart Arrest, Induced , Humans , Infant , Male , Myocardial Ischemia/genetics , Reverse Transcriptase Polymerase Chain Reaction , Stress, Physiological/genetics , Temperature , Time Factors
7.
Clin Chem Lab Med ; 39(12): 1249-58, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11798086

ABSTRACT

The haploinsufficiency of chromosome 22q11.2 can cause both DiGeorge and velocardiofacial syndromes, both of which are characterized by conotruncal heart defects as well as a wide range of other extracardiac anomalies. Several studies have demonstrated that approximately 10-20% of patients with conotruncal heart defects have a 22q11.2 deletion. In clinical laboratories, the deletion is usually detected by fluorescent in situ hybridization (FISH). We set up a polymerase chain reaction-based non-radioactive method for molecular analysis of the 22q11.2 region in conotruncal cardiac patients with conotruncal defects. Sixty-four children with conotruncal defects and their parents were genotyped by polymerase chain reaction, using fifteen polymorphic markers. We identified nine deletions (confirmed by FISH): eight were "de novo" and one familial, maternally inherited. Six deletions were of paternal and three of maternal origin. There were seven deletions of 3 Mb and the other two were of 1.5 Mb. This method is a cost-effective means of characterizing the 22q11.2 region and it can be applied for a rapid screening of 22q11.2 deletion in patients at risk. In agreement with previously published data, we found no correlation between the sizes and the parental origin of deletions and cardiac or extra-cardiac phenotypes.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 22/genetics , Heart Defects, Congenital/genetics , Polymorphism, Genetic/genetics , Tandem Repeat Sequences/genetics , Adolescent , Amino Acid Sequence , Child , Child, Preschool , Female , Genotype , Humans , In Situ Hybridization, Fluorescence , Infant , Male , Pedigree , Polymerase Chain Reaction
8.
J Gerontol A Biol Sci Med Sci ; 54(8): B318-23, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10496537

ABSTRACT

Increases of protein carbonyl in animal tissues have been associated with the aging process. So far, the accumulation of oxidized proteins, highly susceptible to proteolysis, has been attributed to age-related changes in proteasomal alkaline proteases. Carbonyl in protein was monitored in six different tissues of male Sprague-Dawley rats fed ad libitum up to the age of 27 months, and of 24 and 27-month-old rats subjected to anti-aging diet restriction (every-other-day feeding ad libitum). Alkaline protease activities and liver lysosomal proteolysis were studied. The levels of protein carbonyl were significantly different in different tissues, and quite stable throughout life; accumulation was restricted to liver tissue very late in life, between ages 24 and 27 months; was fully prevented by diet restriction; was not accompanied by any diet-restriction-sensitive decline of alkaline protease activity; and was accompanied by a dramatic age-related decline in lysosomal proteolysis that was partially prevented by anti-aging diet restriction. No correlation was found between levels of alkaline protease activity and levels of protein carbonyl in the different tissues from younger animals. It is concluded that the process of autophagy, a well-known mechanism for cell maintenance, may deserve more interest in aging studies.


Subject(s)
Aging/metabolism , Liver/metabolism , Proteins/metabolism , Analysis of Variance , Animals , Chromatography, High Pressure Liquid , Female , Food Deprivation/physiology , Heart Ventricles/metabolism , Kidney/metabolism , Liver/enzymology , Male , Muscle, Skeletal/metabolism , Pancreas/metabolism , Rats , Rats, Sprague-Dawley , Valine/metabolism
9.
J Endocrinol Invest ; 22(11): 835-42, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10710270

ABSTRACT

We report an original application of quantitative reverse transcription-polymerase chain reaction (Q.RT-PCR) for the evaluation of atrial natriuretic factor (ANF), brain natriuretic peptide (BNP) and beta-actin mRNA in small atrial samples (10-15 mg). A fixed amount of total RNA was simultaneously reverse transcribed and amplified with dilutions of a competitor RNA fragment used as a control. We constructed a single synthetic RNA competitor for ANF, BNP and beta-actin. The competitors and targets shared the same primer sequences but yielded PCR products of different sizes. We have investigated ANF, BNP and beta-actin gene expression in patients affected by congenital heart defects (CHD) during the surgical correction of the defect. We collected a right atrial sample from each patient before the start of cardiopulmonary bypass. We studied 14 patients affected by tetralogy of fallot (no. 6), complex CHD (no. 4), and ventricular septal defect (no. 4). The results indicate that the Q.RT-PCR represents a simple, highly specific, non radioactive procedure for the quantification of natriuretic peptide gene expression and is particularly suitable for evaluation of gene expression in small myocardial samples. Our data also suggest that: 1) there is a significant relationship between the levels of ANF, BNP and beta-actin mRNA and the type of CHD; 2) the levels of BNP mRNA are more variable than ANF; 3) the beta-actin seems to be unsuitable for normalising cardiac gene expression in CHD because mRNA basal levels of this protein vary greatly among patients with different type of CHD.


Subject(s)
Atrial Natriuretic Factor/genetics , Heart Defects, Congenital/metabolism , Natriuretic Peptide, Brain/genetics , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Actins/genetics , Binding, Competitive , Blotting, Northern , Child, Preschool , Female , Gene Expression , Heart Atria/chemistry , Heart Defects, Congenital/surgery , Humans , Infant , Male , Myocardium/chemistry , Sensitivity and Specificity
10.
Arch Physiol Biochem ; 103(4): 512-5, 1995 Aug.
Article in English | MEDLINE | ID: mdl-8548491

ABSTRACT

The effects in vivo of the two major in vitro regulatory aminoacids, leucine and glutamine, on liver protein degradation were explored in male young adult Sprague Dawley rats. Protein degradation was stimulated by the injection of the antilipolytic drug 3,5 dimethylpyrazole (DMP), which rises glucagon and lowers insulin plasma levels. At the appropriate time-points (20 and 40 min) after the injection of DMP, glutamine or leucine (12.5 mg/kg b.w.) were injected intraperitoneally. The rate of liver protein breakdown was evaluated 60 min after the injection of DMP on the basis of the release of valine into the perfusate during a short term single pass liver perfusion. The aminoacid was assayed by an HPLC procedure. Results show that the administration of glutamine inhibited the DMP-induced increase in the rate of valine release from the perfused liver whereas the administration of leucine did not; neither of the aminoacids appeared to have any effect on the metabolic or endocrine changes that are required for the induction of liver autophagy and protein breakdown by DMP. It is concluded that the aminoacid glutamine has a powerful action on the in vivo regulation of liver protein breakdown, which is not apparent with leucine.


Subject(s)
Leucine/pharmacology , Liver/drug effects , Proteins/metabolism , Animals , Blood Glucose/metabolism , Fatty Acids, Nonesterified/blood , Insulin/blood , Liver/metabolism , Male , Pyrazoles/pharmacology , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...